Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
Hamish Innes, Victoria Hamill, Scott McDonald, Peter Hayes, Philip Johnson, John Dillon, Jen Bishop, Alan Yeung, April Went, Stephen Barclay, Andrew Fraser, Andrew Bathgate, David Goldberg, Sharon Hutchinson
Risk scores estimating a patient’s probability of a hepatocellular carcinoma (HCC) diagnosis are abundant but are difficult to interpret in isolation. We compared the predicted HCC probability for individuals with cirrhosis and cured hepatitis C with the general population.